Hepatic Veno-Occlusive Disease

"Hepatic Veno-Occlusive Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.

Descriptor ID	D006504
MeSH Number(s)	C06.552.360 C14.907.460
Concept/Terms	Hepatic Veno-Occlusive Disease Hepatic Veno-Occlusive Disease Disease, Hepatic Veno-Occlusive Hepatic Veno-Occlusive Diseases Sinusoidal Obstruction Syndrome Syndrome, Sinusoidal Obstruction Hepatic Veno Occlusive Disease Veno-Occlusive Disease, Hepatic Veno Occlusive Disease, Hepatic

Below are MeSH descriptors whose meaning is more general than "Hepatic Veno-Occlusive Disease".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatic Veno-Occlusive Disease [C06.552.360]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Hepatic Veno-Occlusive Disease [C14.907.460]

Below are MeSH descriptors whose meaning is related to "Hepatic Veno-Occlusive Disease".

Below are MeSH descriptors whose meaning is more specific than "Hepatic Veno-Occlusive Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatic Veno-Occlusive Disease" by people in this website by year, and whether "Hepatic Veno-Occlusive Disease" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 1996

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
2005	1	0	1
2012	0	1	1
2019	0	1	1
2022	1	0	1

Below are the most recent publications written about "Hepatic Veno-Occlusive Disease" by people in Profiles.

Nauffal M, Kim HT, Richardson PG, Soiffer RJ, Antin JH, Cutler C, Nikiforow S, Gooptu M, Koreth J, Romee R, Ho VT. Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant. Blood Adv. 2022 01 11; 6(1):181-188.

View in: PubMed
Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW. Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr. 2019 05 01; 173(5):e190081.

View in: PubMed
Marsh RA, Rao K, Satwani P, Lehmberg K, M?ller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood. 2013 Feb 07; 121(6):877-83.

View in: PubMed
Dunn SP, Tsai A, Griffin G, Toth S, Casas-Melley AT, Falkenstein KP, Marando CA, Krueger LJ. Liver transplantation as definitive treatment for a factor V Leiden mutation. J Pediatr. 2005 Mar; 146(3):418-22.

View in: PubMed
Styler MJ, Crilley P, Biggs J, Moul J, Copelan E, Topolsky D, Avalos B, Penza S, Sabol P, Downs K, Szer J, Brodsky I, Marks DI. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. Bone Marrow Transplant. 1996 Jul; 18(1):171-6.

View in: PubMed
Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD. Bone Marrow Transplant. 1996 Apr; 17(4):549-54.

View in: PubMed
Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1995 Aug; 16(2):271-5.

View in: PubMed
Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ, et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995 Jun; 15(6):949-54.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement